Consensus Elanco Animal Health Incorporated

Equities

ELAN

US28414H1032

Market Closed - Nyse Other stock markets 16:00:02 2024-04-26 EDT			5-day change	1st Jan Change
13.26 ^USD	+1.69%		+2.39%	-11.01%

04-01	Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board	MT
04-01	Elanco appoints two directors after settling with activist Ancora	RE

Evolution of the average Target Price on Elanco Animal Health Incorporated

Price target over the last 5 years

History of analyst recommendation changes

9.QPkXb5uL-GvkMi_P-7XCuznaAooyRGv4OBNnqXHTi0Q.dbBtV9PMyh29eGv-z9aDywGDSMFeCw3PQiAonUG-xw4ik0cDq8zNM6cGQA~50e9784c92f70b8d190aa8bfae94fc70

Analyst Recommendations on Elanco Animal Health Incorporated

Morgan Stanley Adjusts Elanco Animal Health's Price Target to $17 From $16, Keeps Overweight Rating	02-27	MT
Goldman Sachs Raises Price Target on Elanco Animal Health to $14 From $12.50, Maintains Sell Rating	02-27	MT
Barclays Adjusts Price Target on Elanco Animal Health to $19 From $18, Maintains Overweight Rating	02-27	MT
Goldman Sachs Adjusts Elanco Animal Health's Price Target to $12.50 From $10, Keeps Sell Rating	01-17	MT
Stifel Upgrades Elanco Animal Health to Buy From Hold, Raises Price Target Price Target to $20 From $13	01-05	MT
Jefferies Initiates Elanco Animal Health at Buy Rating With $17 Price Target	12-19	MT
Morgan Stanley Upgrades Elanco Animal Health to Overweight From Equalweight, Price Target is $16	12-15	MT
Stifel Trims Price Target on Elanco Animal Health to $12 From $13, Maintains Hold Rating	23-10-30	MT
Piper Sandler Adjusts Price Target on Elanco Animal Health to $13 From $9, Maintains Neutral Rating	23-08-14	MT
Goldman Sachs Adjusts Price Target on Elanco Animal Health to $9.50 From $8.50, Maintains Sell Rating	23-08-08	MT
Piper Sandler Adjusts Elanco Animal Health Price Target to $9 From $12, Maintains Neutral Rating	23-05-15	MT
Goldman Sachs Adjusts Price Target on Elanco Animal Health to $9 From $10.50, Maintains Sell Rating	23-04-25	MT
Barclays Upgrades Elanco Animal Health to Overweight From Equalweight, Price Target is $14	23-04-20	MT
Goldman Sachs Cuts Elanco Animal Health's Price Target to $10.50 From $12, Maintains Sell Rating	23-02-22	MT
Barclays Trims Price Target on Elanco Animal Health to $14 From $18, Keeps Equalweight Rating	23-02-22	MT
Morgan Stanley Adjusts Price Target on Elanco Animal Health to $19 From $20, Maintains Equalweight Rating	23-01-30	MT
Morgan Stanley Adjusts Price Target on Elanco Animal Health to $20 From $21, Maintains Equalweight Rating	22-11-15	MT
Piper Sandler Slashes Price Target on Elanco Animal Health to $15 From $21, Affirms Neutral Rating	22-11-14	MT
JPMorgan Lowers Elanco Animal Health's Price Target to $17 From $20, Maintains Neutral Rating	22-11-09	MT
Goldman Sachs Adjusts Elanco Animal Health Price Target to $12 From $19, Maintains Sell Rating	22-11-09	MT
JPMorgan Chase Lowers Elanco Animal Health's Price Target to $20 From $24, Maintains Neutral Rating	22-10-17	MT
Morgan Stanley Adjusts Elanco Animal Health Price Target to $21 From $22, Maintains Equal Weight Rating	22-10-07	MT
Fitch Affirms Elanco's IDR at 'BB'; Outlooks Remains Negative	22-09-20	AQ
Barclays Adjusts Elanco Animal Health's Price Target to $18 from $32, Reiterates Equalweight Rating	22-09-12	MT
Morgan Stanley Downgrades Elanco Animal Health to Equalweight From Overweight, Cuts Price Target to $22 From $37, Cites Longer 'Constrained' Visibility	22-08-18	MT